Literature DB >> 2463480

Purification of T47D human progesterone receptor and immunochemical characterization with monoclonal antibodies.

G L Greene1, K Harris, R Bova, R Kinders, B Moore, C Nolan.   

Abstract

In order to obtain steroid-independent probes for human progesterone receptor (PR), the A [88-93 kilodalton (kDa)] and B (109-119 kDa) forms of PR from T47D human breast cancer cells were partially purified and used to generate a series of 14 monoclonal antibodies. Initially, unoccupied PR was isolated from cytosol extracts by steroid affinity chromatography, followed by chromatography on diethylaminoethyl Bio-Gel. The partially pure (3-15%) PR consisted of two steroid-binding components that migrated at 89 kDa and 109 kDa in reducing sodium dodecyl sulfate gels after being photoaffinity labeled with the synthetic progestin [3H]R5020. Two unique monoclonal antibodies to PR were derived from a male Lewis rat immunized with this material. One of these antibodies (JU601) was coupled to Sepharose 4B and used to purify T47D nuclear PR for additional immunizations. Highly purified (30-70%) PR migrated as 93 kDa and 119 kDa progestin-binding proteins in sodium dodecyl sulfate gels. In all, thirteen monoclonal antibodies were obtained that recognized epitopes shared by both receptor forms. One mouse immunoglobulin G (KC146) was completely specific for the larger B form. Interestingly, the epitope for this antibody was present on all PRs tested, including the B form of PR from chicken oviduct, whereas nine other antibodies recognized only human PR and the remaining four cross reacted with rabbit PR. With the exception of the JU145 and JU601 rat immunoglobulin Ms, all antibodies appeared to be completely specific for the A or B forms of PR. Each recognized the cytosol and nuclear forms of occupied as well as unoccupied PR. Although the relationship between B and A was not established, it is clear that an amino-terminal region of B is not present in A, and that a significant portion of A and B are either identical or very similar in amino acid sequence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463480     DOI: 10.1210/mend-2-8-714

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Immunohistochemical localization of oestrogen receptors and progesterone receptors in the human ovary throughout the menstrual cycle.

Authors:  T Iwai; Y Nanbu; M Iwai; S Taii; S Fujii; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

2.  Immunocytochemical study of progesterone receptor in human meningioma.

Authors:  M Perrot-Applanat; M T Groyer-Picard; M Kujas
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

Review 3.  Ovarian steroids and serotonin neural function.

Authors:  C L Bethea; M Pecins-Thompson; W E Schutzer; C Gundlah; Z N Lu
Journal:  Mol Neurobiol       Date:  1998-10       Impact factor: 5.590

4.  The ER-positive/PgR-negative breast cancer phenotype is not associated with mutations within the DNA binding domain.

Authors:  S A Fuqua; D C Allred; R M Elledge; S L Krieg; M G Benedix; Z Nawaz; B W O'Malley; G L Greene; W L McGuire
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  Progesterone receptors are expressed in human osteoblast-like cell lines and in primary human osteoblast cultures.

Authors:  P MacNamara; C O'Shaughnessy; P Manduca; H C Loughrey
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

6.  Measurement of steroid hormone receptors in breast cancer patients on tamoxifen.

Authors:  C A Encarnación; D R Ciocca; W L McGuire; G M Clark; S A Fuqua; C K Osborne
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

7.  Immunohistochemical analysis of oestrogen receptors, progesterone receptors and Ki-67 in leiomyoma and myometrium during the menstrual cycle and pregnancy.

Authors:  K Kawaguchi; S Fujii; I Konishi; T Iwai; Y Nanbu; H Nonogaki; Y Ishikawa; T Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

8.  Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand.

Authors:  M F Press; S H Xu; J D Wang; G L Greene
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

9.  Estrogen- and progesterone receptors in normal cycling endometrium as studied by end-point titration.

Authors:  V Ravn; B B Rasmussen; L Højholt; M Barfoed; I Heiberg; B Svenstrup; S M Thorpe
Journal:  Cell Tissue Res       Date:  1994-06       Impact factor: 5.249

10.  Estrogen and progesterone receptors in thyroid lesions.

Authors:  B R Jaklic; J Rushin; B C Ghosh
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.